REFERENCES
- Kan YW. Molecular pathology of α-thalassemia. Ann NY Acad Sci. 1985; 445: 28–36
- Higgs DR, Vickers MA, Wilkie AOM, Pretorius I-M, Jarman AP, Weatherall DJ. A review of the molecular genetics of the human α-globin gene cluster. Blood. 1989; 73(5)1081–1084
- Old JM. Screening and genetic diagnosis of haemoglobin disorders. Blood Rev. 2003; 17(1)43–53
- Yavarian M, Karimi M, Zorai A, Harteveld CL, Giordano PC. Molecular basis of Hb H disease in southwest Iran. Hemoglobin. 2005; 29(1)43–50
- Garshasbi M, Oberkanins C, Law HY, Neishabury M, Kariminejad R, Najmabadi H. α-Globin gene deletion and point mutation analysis among Iranian patients with microcytic hypochromic anemia. Haematologica. 2003; 88(10)1196–1197
- Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acid Res. 1988; 16(3)1215
- Baysal E, Huisman THJ. Detection of common deletional α-thalassemia-2 determinants by PCR. Am J Hematol. 1994; 46(3)208–213
- Nozari G, Rahbar S, Golshalyzan A, Rahmanzadeh S. Molecular analyses of β-thalassemia in Iran. Hemoglobin. 1995; 19(6)425–431
- Yavarian M, Harteveld CL, Batelaan D, Bernini LF, Giordano PC. Molecular spectrum of β-thalassemia in the Iranian province of Hormozgan. Hemoglobin. 2001; 25(1)35–43
- Najmabadi H, Karimi-Nejad R, Sahebjam S, Pourfarzad F, Teimourian S, Sahebjam F, Amirizadeh N, Karimi-Nejad MH. The β-thalassemia mutation spectrum in the Iranian population. Hemoglobin. 2001; 25(3)285–296
- Najmabadi H, Pourfathollah AA, Neishabury M, Sahebjam F, Krugluger W, Oberkanins C. Rare and unexpected mutations among Iranian β-thalassemia patients and prenatal samples discovered by reverse-hybridization and DNA sequencing. Haematologica. 2002; 87(10)1113–1114
- Neishabury M, Oberkanins C, Moheb LA, Pourfathollah AA, Kahrizi K, Keyhany E, Krugluger W, Najmabadi H. High prevalence of the − α3.7 deletion among thalassemia patients in Iran. Hemoglobin. 2003; 27(1)53–55
- Gohari LH, Petrou M, Felekis X, Christopoulos G, Kleanthous M. Identification of α-thalassemia mutations in Iranian individuals with abnormal hematological indices and normal Hb A2. Hemoglobin. 2003; 27(2)129–132
- Harteveld CL, Yavarian M, Zorai A, Quakkelaar ED, van Delft P, Giordano PC. Molecular spectrum of α-thalassemia in the Iranian population of Hormozgan: Three novel point mutation defects. Am J Hematol. 2003; 74(2)99–103
- Pirastu M, Saglio G, Chang JC, Cao A, Kan YW. Initiation codon mutation as a cause of α-thalassemia. J Biol Chem. 1984; 259(20)12315–12317
- Ayala S, Colomer D, Aymerich M, Pujades A, Vives-Corrons JL. Nondeletion α-thalassemia: first description of αHphα and αNcoα mutation in a Spanish population. Am J Hematol. 1996; 52(3)144–149
- El-Kalla S, Baysal E. Thalassemia in United Arab Emirates. Acta Haematologica. 1998; 100(1)49–53
- Altay C, Say B, Yetgin S, Huisman THJ. α-Thalassemia and β-thalassemia in a Turkish family. Am J Hematol. 1977; 2(1)1–15
- Yüregir GT, Aksoy K, Cürük MA. Hb H disease in a Turkish family resulting from the interaction of a deletional α-thalassaemia-1 and a newly discovered poly A mutation. Br J Haematol. 1992; 80(4)527–532
- Samavat A, Modell B. Iranian national thalassaemia screening programme. BMJ. 2004; 329(7475)1134–1137
- Najmabadi H, Ghamari A, Sahebjam F, Kariminejad R, et al. Fourteen-year experience of prenatal diagnosis of thalassemia in Iran. Commun Genet. 2006; 9(2)93–97